Focused on helping its global partners accelerate their research and drug development efforts, Charles River has provided high-quality research models and laboratory animal support expertise for more than 60 years, with an expanding portfolio of services to support discovery and imaging, preclinical and early-phase clinical studies, and biopharmaceutical and endotoxin products and services for manufacturing and quality control. Our unique portfolio spans the entire research and drug development process, from IND consultation to discovery through market approval, allowing flexible, customized approaches to support both single-study or broad-based programs.
Learn more at www.criver.com.